Immune reconstitution after antiretroviral treatment;Reconstitution immune apres traitements anti-retroviraux

Presse Medicale

Volumn 28, Issue 8, 1999, Pages 424-428

  Tubiana, R ^a   Carcelain, G ^a   Ait Mohand, H ^a   Li, T S ^a   Renaud, M ^a   Blanc, C ^a   Calvez, V ^a   Debre P ^a   Agut, H ^a   Katlama, C ^a   Autran, B ^a   Bricaire, F ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ANTIVIRUS AGENT;

ANTIBIOTIC THERAPY; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPHOCYTE; LYMPHOID ORGAN; OPPORTUNISTIC INFECTION; VIRUS LOAD; DRUG COMBINATION; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNITY; IMMUNOLOGY; RETROVIRUS; T LYMPHOCYTE;

ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNITY; RETROVIRIDAE; T-LYMPHOCYTES;

EID: 0033608275     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hammer SM, Squires KE, Hugues MD et al. A controlled trial of two nucleoside analogues plus indinavir in patients with human, immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997 ; 337:725-33.
2. Gulick RM, Mellors JW, Havlir D et al. Treatment with indinavir, zidovudine and lamivudine in adults with human immunodeficiency virus infection and prior anti-retroviral therapy. N Engl J Med 1997 ; 337:734-9.
3. Palella FJ, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998 ; 338:853-908.
4. Hogg RS, O'Shaughnessy MV, Gataric N et al. Decline in deaths from AIDS due to new antiretrovirals. Lancet 1997 ; 349:1294.
5. Reed JB, Schwab IR, Gordon J et al. Regression of Cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS. Ame J Ophtal 1997 ; 124:199-205.
6. e conférence internationale sur le sida, Geneve 1998 abst 12345.
7. Carr A, Merriott D, Field A et al. Combination antiretroviral therapy of HIV associated micropsporidiosis and cryptosporidiosis Lancet 1998 ; 351:256-61.
8. Elliot B, Aromin I, Gold R et al. 2.5 years remission of AIDS-associated progressive multifocal encephalopathy with combined antiretroviral therapy. Lancet 1997 ; 349:850.
9. Murphy M, Armstrong D, Sepkowitz KA et al. Regression of AIDS-related Kaposi sarcoma following treatment with an HIV1 prrotease inhibitor. AIDS 1997 ; 11:261-2.
10. Schneider MME, Borleff JCC, Stolk RP et al. Discontinuation of prophylaxis for pneumocystis carinii pneumonia in HIV1 infected patients treated with highly active antiretroviral therapy. Lancet 1999; 353:201-3.
11. Tural C, Romeu J, Sirera G et al. Long lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients. J Infect Dis 1998 ; 177:1080-3.
12. Rinaldo C, Huang XL, Piazza P et al. Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients. J Infect Dis 1991 ; 164:638-45.
13. Clerici M, Landay AL, Kessler HA et al. Reconstitution of long term T helper cell function after zidovudine therapy in human immunodeficiency virus-infected patients. J Infect Dis 1992 ; 166:723-30.
14. French MAH, Mallal SA, Dawkins RL. Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV+ infected patients. AIDS 1992 ; 6:1293-7.
15. Kelleher AD, Carr A, Zaunders J, Cooper DA. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, Ritonavir. J Infect Dis 1996 ; 173:321-9.
16. Autran B, Carcelain G, Li TS et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997 ; 277:112-16.
17. Li TS, Tubiana R, Katlama C et al. Long lasting recovery in CD4+ T cell function and viral load reduction after highly active anti-retroviral therapy in patients with advanced HIV disease. Lancet 1998 ; 351:1682-6.
18. Mackall CL, Granger L, Sheard MA et al. T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood 1993 ; 82:2585-394.
19. Giorgi JV, Fahey JL, Smith DC et al. Early effects of HIV on CD4 lymphocytes in vivo. J Immunol 1987 ; 138:3725-30.
20. Dolan MJ, Clerici M, Blatt SP et al. In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis 1995 ; 172:79-87.
21. Hoy JF, Lewis DE, Miller GG. Functional versus phenotypic analysis of T cells in subjects seropositive for the human immunodeficiency virus: a prospective study of in vitro response to Cryptococcus neoformans. J Infect Dis 1988 ; 158:1071-8.
22. Lane HC, Masur H, Gelmann EP et al. Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. Am J Med 1985 ; 78:417-22.
23. Goujard C, Wallon C, Taoufik Y et al. Delayed and sustained immunologic recovery after 15 months of active antiretroviral therapy. Abstract. 163.5th Conference on retroviruses and opportunistic infections. Chicago, February 1998.
24. e conférence internationale sur le sida, Geneve 1998 abst 12247.
25. 6 cells/l following combination antiretroviral therapy including protease inhibitors. AIDS 1997 ; 11:1659-60.
26. Jacobson MA, Zegans M, Pavan PR et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997 ; 349:1443-5.
27. e conférence internatinale sur le sida Geneve 1998 abst 22323.
28. e conférence internationale sur le sida, Geneve 1998 abst 22240.
29. e conference internatinale sur le sida Geneve 1998 abst 426.
30. De Peoli P, Zanussi S, Simonelli C et al. Effects of subcutaneous IL-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ patients. Abstract 609. 5th Conference on retrovirus and opportunistic infections. Chicago. February 1998.
31. Emery S, Capra W, Vig P et al. IL-2 therapy for HIV disease: a meta-analysis of three randomized controlled tirals. Abstract 608. 5th Conference on Retrovirus and opportunistic infections. Chicago, February 1998.
32. 3: preliminary results. Abstract 611. 5th Conference on retroviruses and opportunistic infectious, Chicago, February 1998.